Prime Medicine, Inc. (PRME) Live Share Price, Invest From India

Prime Medicine, Inc. Stock Performance

as on January 28, 2026 at 9:42 pm IST

Day's Low
Day's High
$4.05
Day's Price Range
$4.40
$4.11
1.46%
Downside
7.06%
Upside
52 Week's Low
52 Week's High
$1.11
52-Week Price Range
$6.94
$4.11
72.99%
Downside
68.86%
Upside

Prime Medicine, Inc. share price movements today

Previous Close: $4.28
Open: $4.34
Volume: 502.1K
Day's Low - High: $4.05 - $4.40
52 Week Low - High: $1.11 - $6.94

Prime Medicine, Inc. Historical Returns

1 Month Return: + 22.29 %
3 Month Return: -11.2 %
1 Year Return: + 51.24 %
3 Year Return: -75.47 %
5 Year Return: 0 %

Prime Medicine, Inc. Stock Fundamentals & Key Indicators

Check Prime Medicine, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$754.5M

EPS (TTM)

-1.2834

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-196.8M

Revenue (TTM)

6.0M

Profit Margin

0.00%

Return On Equity TTM

-112.34%

Prime Medicine, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Prime Medicine, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Prime Medicine, Inc.	BUY	$754.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	129.26%	1246.03	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	106.13%	33.56	31.35%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	52.34%	18.28	32.13%

Stock Returns calculator for Prime Medicine, Inc. Stock including INR - Dollar returns

The Prime Medicine, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Prime Medicine, Inc. investment value today

Current value as on today

₹1,51,204

Returns

₹51,204

(+51.2%)

Returns from Prime Medicine, Inc. Stock

₹45,230 (+45.23%)

Dollar Returns*

₹5,974 (+5.97%)

Analyst Recommendation on Prime Medicine, Inc. Stock

Based on 17 analysts

BUY

76.47%

Buy

23.53%

Hold

0.00%

Sell

Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Prime Medicine, Inc.. Average target price of $6.46

Prime Medicine, Inc. Share Price Target

Get share price movements and forecasts by analysts on Prime Medicine, Inc..

What analysts predicted

36.38%UPSIDE

Target Price

$6.46

Current Price

$4.11

Analyzed by

17 Analysts

Target

$6.46

Prime Medicine, Inc. target price $6.46, a slight upside of 36.38% compared to current price of $4.11. According to 17 analysts rating.

Prime Medicine, Inc. Stock’s Investor Sentiment and Interest

Investment in Prime Medicine, Inc. Shares on INDmoney has grown by 293.75% over the past 30 days, indicating increased transactional activity.

Time period: December 29, 2025 to January 28, 2026

Change:293.75% versus previous 30 day period

Search interest for Prime Medicine, Inc. Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Time period: December 29, 2025 to January 28, 2026

Change:63% versus previous 30 day period

Prime Medicine, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	25	0	37	0	2	1	1	1
Gross Profit	-4	-4	-1	0	-1	0	2	1	0	-42
Operating Income	-45	-51	-68	-48	-55	-54	-44	-52	-53	-53
EBITDA	-44	-50	-53	-47	-54	-52	-42	-50	-51	-48
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-42	-50	-65	-45	-55	-52	-42	-51	-52	-50
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-42	-50	-65	-45	-55	-52	-42	-51	-52	-50
Net Profit Margin	0.00%	0.00%	-255.50%	-7742.98%	-146.47%	-25128.23%	-1936.60%	-3568.78%	-4716.68%	-4129.14%

Prime Medicine, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	5	-	5	-	2
Gross Profit	2	-4	-12	-4	2
Operating Income	0	-84	-116	-204	-202
EBITDA	0	-83	-114	-186	-196
Interest Expense	10	81	12	-	-
Depreciation	0	0	2	4	6
Income Before Tax	-1	-165	-122	-198	-195
Income Tax Expense	1	0	0	0	-
Net Income	-3	-165	-121	-198	-195
Net Profit Margin	-65.45%	0.00%	-2338.21%	0.00%	-6566.61%

Prime Medicine, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-50	-65	-45	-55	-52	-42	-51	-52	-50
Operating Cash Flow	-39	-43	-67	-45	-25	16	-48	-41	-35
Investing Cash Flow	-37	41	-37	6	50	48	-47	2	-92
Financing Cash Flow	0	0	157	0	38	0	6	0	144
Change in Cash	-76	-2	52	-38	62	64	-90	-38	17

Prime Medicine, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-165	-121	-198	-195
Operating Cash Flow	-5	-34	-131	-165	-122
Investing Cash Flow	-1	-73	-47	18	68
Financing Cash Flow	34	269	181	0	195
Change in Cash	28	161	2	-146	141

Global Institutional Holdings in Prime Medicine, Inc.

Funds	Holdings
Northern Trust Corp	0.29%
Alphabet Inc	8.45%
Vanguard Group Inc	2.03%
MWG Management Ltd.	1.01%
Citadel Advisors Llc	0.29%

See all

Insights on Prime Medicine, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PRME has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, PRME stock has moved up by 22.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 104.9%

About Prime Medicine, Inc.

Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering gene editing therapies to patients. It deploys its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. It is advancing a set of high-value programs across its core areas of focus (hematology, immunology and oncology, liver, and lung). These include ex vivo hematopoietic stem cell (HSC) programs for the treatment of p47phox chronic granulomatous disease CGD and X-linked CGD; a lipid nanoparticle (LNP) Prime Editor for the treatment of Wilson’s Disease; a LNP or adeno-associated virus Prime Editors for the treatment of cystic fibrosis; and ex vivo T-cell therapies. PM359, its product candidate within its hematology, immunology and oncology area of focus, targets the p47phox variant of CGD. Its PM577 comprises a Prime Editor encapsulated as RNA cargo in a liver-targeted LNP.

Organisation	Prime Medicine, Inc.
Headquarters	60 First Street, Cambridge, MA, United States, 02141
Industry	Healthcare
CEO	Dr. Allan Reine M.D.
E-voting on shares	Click here to vote

Key Management of Prime Medicine, Inc.

Name	Title
Dr. Allan Reine M.D.	CEO & Director
Dr. Andrew Anzalone M.D., Ph.D.	Co-Founder
Mr. Ryan E. Brown J.D.	Chief Legal Officer
Ms. Niamh Alix	Chief Human Resources Officer
Mr. Mohammed Asmal M.D., Ph.D.	Senior VP & Head of Clinical
Mr. Jeffrey D. Marrazzo M.B.A., M.P.A.	Executive Chair
Dr. Keith Michael Gottesdiener M.D., Ph.D.	Consultant
Dr. David R. Liu Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Ann L. Lee Ph.D.	Chief Technical Officer
Dr. Matthew J. Hawryluk M.B.A., Ph.D.	Chief Business Officer

FAQs

What is Prime Medicine, Inc. share price today?

Prime Medicine, Inc. share price today is $4.11 as on January 28, 2026 at 9:42 pm IST. Prime Medicine, Inc. share today touched a day high of $4.4 and a low of $4.05.

What is the 52 week high and 52 week low for Prime Medicine, Inc. share?

Prime Medicine, Inc. share touched a 52 week high of $6.94 on October 6, 2025 and a 52 week low of $1.11 on May 22, 2025. Prime Medicine, Inc. stock price today i.e. January 28, 2026 at 9:42 pm IST is trending at $4.11,which is 40.78% down from its 52 week high and 270.27% up from its 52 week low.

What is Prime Medicine, Inc.'s market capitalisation today?

Prime Medicine, Inc. market capitalisation is $0.00T as on January 28, 2026 at 9:42 pm IST.

How to invest in Prime Medicine, Inc. Stock (PRME) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Prime Medicine, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Prime Medicine, Inc. Shares that will get you 0.3650 shares as per Prime Medicine, Inc. share price of $4.11 per share as on January 28, 2026 at 9:42 pm IST.

What is the minimum amount required to buy Prime Medicine, Inc. Stock (PRME) from India?

Indian investors can start investing in Prime Medicine, Inc. (PRME) shares with as little as ₹91.762 or $1 (as of January 28, 2026 at 9:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Prime Medicine, Inc. stock (as per the Rupee-Dollar exchange rate as on January 28, 2026 at 9:42 pm IST). Based on Prime Medicine, Inc. share’s latest price of $4.11 as on January 28, 2026 at 9:42 pm IST, you will get 2.4331 shares of Prime Medicine, Inc.. Learn more about fractional shares .